EUVIMEDEUVIMED entdecken
Crossref

Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019

J Evers, M J C van der Sangen, M C van Maaren, J H Maduro, L Strobbe, M J Aarts, M C W M Bloemers, D H J G van den Bongard, H Struikmans, S Siesling

Clinical Oncology · 2024

DOI: 10.1016/j.clon.2024.08.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2024. Verfasst von J Evers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands; Univers…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This nationwide study provides an overview of trends and variations in radiotherapy use as part of multimodal treatment of invasive non-metastatic breast cancer in the Netherlands in 2008-2019. MATERIALS AND METHODS: Women with invasive non-metastatic breast cancer were selected from the population-based Netherlands Cancer Registry. Treatments trends were presented over time. Factors associated with (1) boost irradiation in breast-conserving therapy and (2) regional radiotherapy instead of axillary lymph node dissection (ALND) in N+ disease were identified using multilevel logistic regression analyses. RESULTS: Radiotherapy use increased from 61% (2008) to 70% (2016), caused by breast-conserving therapy instead of mastectomy, increased post-mastectomy radiotherapy, and increased regional radiotherapy (32% in 2011 to 61% in 2019) instead of ALND in N+ disease. Omission of radiotherapy after breast-conserving surgery (BCS) in 2016-2019 (4-9%, respectively), mainly in elderly, decreased overall radiotherapy use to 67%. Radiotherapy treatment was further de-escalated by decreased boost irradiation in breast-conserving therapy (66% in 2011 to 37% in 2019) and partial (1% in 2011 to 6% in 2019) instead of whole breast irradiation following BCS. Boost irradiation was associated with high-risk features: younger age (OR>75 vs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleNetherlandsMiddle AgedAgedAdultMastectomy, SegmentalRadiotherapy, AdjuvantAged, 80 and overRegistriesCombined Modality TherapyLymph Node Excision

Stichwörter der Autor:innen

axillary radiotherapyboost irradiationbreast-conserving therapyepidemiologynon-metastatic breast cancerradiotherapy

Autor:innen und Institutionen

  • Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands; University of Twente, Department of Health Technology and Services Research,…
  • Catharina Hospital, Department of Radiation Oncology Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands.
  • University of Twente, Department of Health Technology and Services Research, Technical Medical Center, Hallenweg 5, 7522 NH Enschede, The Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Department of…
  • University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.
  • Canisius Wilhelmina Hospital, Department of Surgery Weg door Jonkerbos 100, 6532 SZ Nijmegen, The Netherlands.
  • Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, PO Box 19079, 3501 DB Utrecht, The Netherlands.

Zitieren

APA

Evers, J., van der Sangen, M. J. C., van Maaren, M. C., Maduro, J. H., Strobbe, L., Aarts, M. J., Bloemers, M. C. W. M., van den Bongard, D. H. J. G., Struikmans, H., & Siesling, S. (2024). Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019. Clinical Oncology. https://doi.org/10.1016/j.clon.2024.08.010

Vancouver

Evers J, van der Sangen MJC, van Maaren MC, Maduro JH, Strobbe L, Aarts MJ, et al. Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019. Clinical Oncology. 2024. doi:10.1016/j.clon.2024.08.010

BibTeX
@article{Evers2024,
  author = {Evers, J and van der Sangen, M J C and van Maaren, M C and Maduro, J H and Strobbe, L and Aarts, M J and Bloemers, M C W M and van den Bongard, D H J G and Struikmans, H and Siesling, S},
  title = {Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019},
  journal = {Clinical Oncology},
  year = {2024},
  doi = {10.1016/j.clon.2024.08.010}
}
Kostenlos starten →